| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52,6 M € | +19.4% | 44,0 M € | +3.8% | 42,4 M € | +14.9% | 36,9 M € | -15.6% | 43,8 M € | +27.5% | 34,3 M € | +6.4% | 32,2 M € | +7.2% | 30,1 M € | +18.5% | 25,4 M € | +7.4% | 23,6 M € | -4.9% | 24,9 M € | +2.1% | 24,4 M € | +24.3% | 19,6 M € | +1.9% | 19,2 M € | +8.3% | 17,7 M € | +22.8% | 14,5 M € | +18.5% | 12,2 M € | -40.9% | 20,7 M € | |
| EBITDA | 23,8 M € | +66.6% | 14,3 M € | -7.3% | 15,4 M € | +12.0% | 13,8 M € | -9.6% | 15,2 M € | +18.3% | 12,9 M € | -11.8% | 14,6 M € | -3.5% | 15,1 M € | +5.3% | 14,4 M € | +73.5% | 8,3 M € | -27.3% | 11,4 M € | +1.7% | 11,2 M € | +29.4% | 8,7 M € | -2.0% | 8,8 M € | +10.6% | 8,0 M € | -7.4% | 8,6 M € | +41.8% | 6,1 M € | -32.9% | 9,1 M € | |
| Operating profit | 10,5 M € | +670.5% | 1,4 M € | -48.8% | 2,7 M € | +38.1% | 1,9 M € | -54.1% | 4,2 M € | +43.7% | 2,9 M € | -44.7% | 5,3 M € | -20.8% | 6,6 M € | +20.8% | 5,5 M € | +4125.3% | 130,3 k € | -96.4% | 3,6 M € | -0.2% | 3,6 M € | +178.4% | 1,3 M € | -34.3% | 2,0 M € | +52.7% | 1,3 M € | -36.6% | 2,0 M € | +140.8% | 851,0 k € | -81.9% | 4,7 M € | |
| Profit/loss | 10,6 M € | +294.6% | 2,7 M € | -56.1% | 6,1 M € | +216.2% | -5,2 M € | -190.8% | 5,8 M € | -13.9% | 6,7 M € | +42.3% | 4,7 M € | -71.1% | 16,3 M € | +3.3% | 15,8 M € | +941.5% | 1,5 M € | -84.1% | 9,6 M € | +850.8% | 1,0 M € | -65.8% | 2,9 M € | +2.0% | 2,9 M € | -10.2% | 3,2 M € | -19.0% | 4,0 M € | +50.8% | 2,6 M € | -54.4% | 5,8 M € | |
| Equity | 172,4 M € | +7.0% | 161,1 M € | +1.0% | 159,5 M € | +3.5% | 154,2 M € | -1.7% | 156,8 M € | +4.8% | 149,6 M € | +6.9% | 140,0 M € | +3.1% | 135,8 M € | +16.1% | 116,9 M € | +14.6% | 102,0 M € | +3.9% | 98,2 M € | +11.1% | 88,3 M € | +0.1% | 88,3 M € | +4.6% | 84,4 M € | +11.5% | 75,7 M € | +3.8% | 73,0 M € | +3.7% | 70,4 M € | +10.1% | 63,9 M € | |
| Total assets | 323,7 M € | +4.7% | 309,1 M € | +4.6% | 295,4 M € | +9.2% | 270,6 M € | +6.2% | 254,8 M € | +3.9% | 245,3 M € | +6.7% | 229,9 M € | +1.7% | 226,1 M € | +14.7% | 197,1 M € | +23.5% | 159,5 M € | +0.9% | 158,1 M € | +2.5% | 154,3 M € | -1.2% | 156,2 M € | +5.6% | 147,9 M € | +1.1% | 146,3 M € | +6.6% | 137,3 M € | +2.9% | 133,5 M € | +5.1% | 127,0 M € | |
| Cash | 5,0 M € | -30.3% | 7,2 M € | -61.0% | 18,4 M € | -38.5% | 29,9 M € | +7.5% | 27,8 M € | -21.4% | 35,4 M € | -6.7% | 37,9 M € | -6.3% | 40,5 M € | +30.5% | 31,0 M € | +83.0% | 16,9 M € | +16.2% | 14,6 M € | +25.7% | 11,6 M € | +159.7% | 4,5 M € | -48.8% | 8,7 M € | +514.1% | 1,4 M € | +561.2% | 214,7 k € | +52.1% | 141,1 k € | -74.2% | 546,8 k € | |
| Debts | 84,8 M € | +3.4% | 82,1 M € | +3.3% | 79,4 M € | +10.6% | 71,8 M € | +15.3% | 62,3 M € | -7.1% | 67,0 M € | +10.6% | 60,6 M € | -7.7% | 65,6 M € | +10.2% | 59,6 M € | +21.2% | 49,1 M € | +1.5% | 48,4 M € | -10.6% | 54,1 M € | -1.8% | 55,1 M € | +9.6% | 50,3 M € | -0.2% | 50,4 M € | +13.6% | 44,4 M € | +8.0% | 41,1 M € | +5.3% | 39,0 M € | |
| Staff | 928,4 | 885,2 | 835,2 | 796 | 748,1 | 743,1 | 724,2 | 668,1 | 610,3 | 577 | 583,1 | 570,1 | 552,3 | 530,4 | 502,9 | 508 | 500,6 | 464,2 | ||||||||||||||||||
Non-profit organization · Gent · incorporated on 06/07/1995 · 928,4 ETP
Non-profit organization profitable and well capitalised. Cash position declining (-30.3%).
Solid counterparty for a standard engagement.
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY is a Non-profit organization incorporated in 1995. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 928,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette